Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. California Pharmacy & Compounding Center
483
•California Pharmacy & Compounding Center•August 31, 2016

California Pharmacy & Compounding Center – FDA 483, Aug 31, 2016

Record Details

The FDA Form 483 details observations from an inspection of an outsourcing facility. Key deficiencies relate to sterile drug product manufacturing and labeling.

**Sterilization Process Validation:** * **Media Fills:** Inadequate, failing to simulate worst-case scenarios (e.g., longest production times, human interventions) as per WI-101-003-003. Specific examples include Bevacizumab PFS production not meeting maximum filling time. Growth promotion challenges lacked gram-negative bacteria and in-house representative isolates. Incorrect media was used for Lidocaine HCL/Phenylephrine HCL media fill. Rejected vials/syringes with particulates/defects were not included in incubation. * **Smoke Studies:** Conducted on (b) (4) for ISO 5 Laminar Flow Hoods, but not under dynamic conditions. They failed to assure unidirectional airflow under working conditions and ingress prevention of ISO 7 air into ISO 5. Components/equipment (e.g., (b) (4)) and operator movements were not included.

**Environmental Monitoring & Air Supply:** * **Personnel Monitoring:** Lacks scientific rationale to assure aseptic processing. Samples (e.g., around (b) (4)) were taken (b) (4). * **HEPA Filter Certification:** (b) (4) certifications for ISO 7 and ISO 8 rooms did not include HEPA filter leak testing for filters

Company
California Pharmacy & Compounding Center
Inspection date
August 31, 2016
Product type
Drugs
Office
Los Angeles District Office
Person
  • Linda Thai (Team Biologics Staff)
View Company Profile

ID · 5d52aece-cf3d-4cb0-b3fe-15977471941f

Violation Codes6
21 U.S.C. 324(a)(4)FD&C Act 905(j)21 CFR 21021 CFR 211FD&C Act 801(a)(3)21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for California Pharmacy & Compounding Center
  • 483 - 2018-12-17December 17, 2018
  • AMENDED_483 - 2018-12-07December 7, 2018
  • 483 - 2017-04-21April 21, 2017
  • 483 - 2014-10-17October 17, 2014
  • WARNING_LETTER - 2014-10-17October 17, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore California Pharmacy & Compounding Center
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.